TE_152
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L2 |
|---|---|
| TE superfamily | L2 |
| TE class | LINE |
| Gene | FBXO42, - |
| Class | Chimeric, Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 0.76 |
| Counts of samples | TCGA_tumor:152; TCGA_normal:10; GTEx:217 |
| TSS | chr1(-):16284466 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_152.1 | FBXO42 | Chimeric | Non-coding | Non-coding | chr1(-):16251765,16251785,16252288,16252404,16253096,16253152,16253635,16253731,16255711,16255821,16256606,16256759,16284278,16284467 |
| teRNA_152.2 | - | Intergenic | Non-coding | Non-coding | chr1(-):16261146,16261166,16284278,16284467 |
| teRNA_152.3 | - | Intergenic | Non-coding | Non-coding | chr1(-):16259576,16259596,16261001,16261166,16284278,16284467 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
